Fall 2010 Symposium


Pre-Clinical Research in COPD and Pulmonary Fibrosis

Friday, October 15th 2010

Pfizer Facility – Building J
1 Burtt Road

Andover, MA 01810

Organizers:
Cara Williams, Ph.D., Pfizer Inc.
Lennart K.A. Lundblad, Ph.D., University of Vermont
Jonathan Phillips, Ph.D., Hoffmann-La Roche, Inc.


MEETING Agenda, directions, and accomidations (PDF file)

Click Here For Online Registration, Directions, and Accommodations
Registration is Mandatory for Attendance

Presentations:

Richard Pierce : Washington University, St. Louis, MO

· Airways Disease-Specific Pathways in Chronic Pulmonary Obstructive Disease (COPD).

Martin Stampfli : McMaster University, Hamilton, Ontario

· Cigarette smoke and respiratory host defense: Implications for smoking-related diseases.

Martin Kolb: McMaster University, Hamilton, Ontario

· Mesenchymal progenitor cells in lung fibrosis – News about pathogenesis and their potential clinical role.

Bela Suki - Boston University, Boston, MA

· Interaction Between Mechanical Forces and Elastase Activity in the Normal and Emphysematous Lung.

Lynne Murray: MedImmune

· Commonalities between COPD and IPF fibrosis.

Thomas Wynn: NIH, Bethesda, MD

· Distinct roles for IL-13 and IL-17a in pulmonary inflammation and fibrosis.

Jonathan Phillips: Roche, Nutley, NJ

· Increased work of breathing from bleomycin induced fibrosis in the mouse lung.

Aaron Winkler, Pfizer, Andover, MA

· In vitro modeling of human alveolar macrophage smoke exposure: Enhanced inflammation, impaired function, and regulation of histone deacetylases.

Return to PRG Home Page







© Jon Phillips 2008